Article Listing - EMEA accepts Vidaza for accelerated review

NITRATES: OLD DRUGS, BUT ONES WITH A FUTURE

20 April 1992

Interest in nitrate products as potential drugs to improve the prognosis of patients with acute myocardial infarction (MI) is steadily...

GEHE SALES AND PROFITS grow IN 1991

20 April 1992

German Drug manufacturer Gehe made group sales in 1991 of just over 5 billion Deutschemarks ($3 billion), an increase of...

IMEX HEMOFARM IN MOSCOW

20 April 1992

The Imex Hemofarm pharmaceutical concern based in Vrsac in Serbia has opened a representative office in Moscow in order to...

US Rx DRUG PRICES UP 4.1% IN 1ST QUARTER

20 April 1992

The US Bureau of Labor Statistics reports that prices of prescription drug products increased by an average of 4.1% in...

JAPANESE THREAT "INTENSIFYING"

20 April 1992

Japanese pharmaceutical companies must be regarded as world market competitors more speedily than had originally been expected, according to Hans...

STOCK MARKET COMMENTARY: TOKYO

20 April 1992

TOKYO: finished the week with a 6.5% loss at 17,236 yen on Monday April 13, despite a sharp 1,252 point...

STOCK MARKET COMMENTARY: EUROPE

20 April 1992

EUROPE: saw most of its stock markets down on the week, following the free-fall in Tokyo and poor performance of...

APPOINTMENTS AT MARION MERRELL DOW

20 April 1992

Appointments at Marion Merrell Dow: Allan Mills is named as product director for cardiovascular products; Norman Craig is appointed as...

NEW PRESIDENT FOR STERLING HEALTH CANADA

20 April 1992

Robert Steinman has been named as president of non-prescription drug company Sterling Health Canada.

EFAs COULD REFORM ANTIVIRAL THERAPY

20 April 1992

A new approach to treating viral infections, and one which could be synergistic with other antiviral strategies, was described in...

Showing 94421-94430 of 95582 articles

Go to beginningPreviousNextGo to end